it could be, but I don't think Barda, because of h
Post# of 36537
At first glance, it seemed to me a "last resort" operation that denotes the perennial chronic lack of funds and financiers, also confirmed by the recent small dilution (a question arises: where are Bintai and the Chinese who should have financed "in full" the vaccine ??) ....
But perhaps it is simply an advertising maneuver to attract some attention (... unfortunately, and the volumes confirm, there is little interest around Generex ...)
For sure, it's not the pr I would have expected, lacking any concrete consistency ...